Observational × Carcinoma, Transitional Cell × Gastrointestinal × Clear all Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Recruiting
300 enrolled
IMreal
Active not recruiting
2,756 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
ST-ICI02
Recruiting
200 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
POSITive
Unknown
265 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Completed
1,758 enrolled
PIONEER
Unknown
1,000 enrolled
A Study of Personalized Neoantigen Cancer Vaccines
Completed
93 enrolled